Fridkin SK, Cleveland AA, See I, Lynfield R. Emerging Infections Program as surveillance for antimicrobial drug resistance. Emerg Infect Dis. 2015;21(9):1578–81.
Hadler JL, Vugia DJ, Bennett NM, Moore MR. Emerging Infections Program efforts to address health equity. Emerg Infect Dis. 2015;21(9):1589–94.
Hadler JL, Danila RN, Cieslak PR, et al. Emerging Infections Program–State health department perspective. Emerg Infect Dis. 2015;21(9):1510–5.
Langley G, Schaffner W, Farley MM, et al. Twenty years of Active Bacterial Core surveillance. Emerg Infect Dis. 2015;21(9):1520–8.
Langley G, Besser J, Iwamoto M, et al. Effect of culture-independent diagnostic tests on future Emerging Infections Program surveillance. Emerg Infect Dis. 2015;21(9):1582–8.
Lynfield R, Schaffner W. Emerging Infections Program–20 years of achievements and future prospects. Emerg Infect Dis. 2015;21(9):1497–8.
Pinner RW, Lynfield R, Hadler JL, et al. Cultivation of an adaptive domestic network for surveillance and evaluation of emerging infections. Emerg Infect Dis. 2015;21(9):1499–509.
Vugia DJ, Meek JI, Danila RN, et al. Training in infectious disease epidemiology through the Emerging Infections Program sites. Emerg Infect Dis. 2015;21(9):1516–9.
Olsen R, Fittipalide N, Kachroo P, et al. Clinical laboratory response to a mock outbreak of invasive bacterial infections: A preparedness study. J Clin Microbiol. 2014;2(12):4210-6.
Srinivasan V, Metcalf BJ, Knipe KM, et al. vanG element insertions within a conserved chromosomal site conferring vancomycin resistance to Streptococcus agalactiae and Streptococcus anginosuMBio. 2014;5(4):e01386-14.
Whitney CG, Zhou F, Singleton J, Schuchat A. Benefits from immunization during the vaccines for children program era – United States, 1994-2013. MMWR Morb Mortal Wkly Rep. 2014;63(16):352-5.
Dawood FS, Chaves SS, Pérez A, et al. Complications and associated bacterial co-infections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010. J Infect Dis. 2014;209(5):686–94.
Deutscher M, Lewis M, Zell ER, et al. Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis. 2011;53(2):114-23.
Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30(11):937-41.
Burton DC, Flannery B, Bennett NM, et al. Socioeconomic and racial/ethinic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health. 2010;100(10):1904-11.
Van Beneden C, Olsen S, Skoff T, Lynfield R. Active, population-based surveillance for infectious diseases. In: M’ikanatha NL R; Van Beneden CA; de Valk H, ed. Infectious Disease Surveillance. 1st ed: Blackwell Publishers, pp. 32-43, 2007.
Begier EM, Barrett NL, Mshar PA, Johnson DG, Hadler JL, Connecticut Bioterrorism Field Epidemiology Response Team. Gram-positive rod surveillance for early anthrax detection. Emerg Infect Dis. 2005;11(9):1483-6.
Pinner RW, Rebmann CA, Schuchat A, Hughes JM. Disease surveillance and the academic, clinical, and public health communities. Emerg Infect Dis. 2003;9(7):781-7.
Centers for Disease Control and Prevention. HIV testing among pregnant women, United States and Canada, 1998-2001. MMWR Morb Mortal Wkly Rep. 2002;51(45):1013-6.
Hyde T, Hilger T, Reingold A, Farley MM, O’Brien, Schuchat A. Trends in incidence and antimicrobial resistance of early-onset sepsis: Population-based surveillance in San Francisco and Atlanta. Pediatrics. 2002;110:690-5.
Schuchat A, Hilger T, Zell E, et al. Update from the Active Bacterial Core surveillance of the Emerging Infections Program network. Emerg Infect Dis. 2001;7(1):92-9.
Centers for Disease Control and Prevention. Laboratory capacity to detect antimicrobial resistance, 1998. MMWR Morb Mortal Wkly Rep. 2000;48(51):1167-71.
Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis. 1999;5(5):607-25.
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.